Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20 JPY | 0.00% | -4.76% | -13.04% |
Sep. 18 | OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index | CI |
May. 12 | OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Business Summary
Number of employees: 60
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Precision Medical Services
99.2
%
| 1,146 | 99.4 % | 1,126 | 99.2 % | -1.81% |
Research and Development of Pharmaceutical Products and Related Business
0.8
%
| 7 | 0.6 % | 9 | 0.8 % | +27.48% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 1,154 | 100.0 % | 1,135 | 100.0 % | -1.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Junichi Shimada
PSD | President | 62 | 21-11-30 |
Zehyon Paku
CTO | Chief Tech/Sci/R&D Officer | 48 | 17-06-30 |
Yuichi Komine
BRD | Director/Board Member | 52 | 08-05-31 |
Yuka Yamane
AUD | Comptroller/Controller/Auditor | 51 | 02-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yuichi Komine
BRD | Director/Board Member | 52 | 08-05-31 |
Zehyon Paku
CTO | Chief Tech/Sci/R&D Officer | 48 | 17-06-30 |
Hatsuo Kato
CHM | Chairman | 80 | 20-05-31 |
Yoshio Miki
BRD | Director/Board Member | 67 | 22-05-31 |
Junichi Shimada
PSD | President | 62 | 21-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 217,643,700 | 177,261,700 ( 81.45 %) | 0 | 81.45 % |
Company contact information
OncoTherapy Science, Inc.
Ichigo Kawasaki Building 1-2 Higashidacho
210-0005, Kawasaki
+81 4 4201 6429
http://www.oncotherapy.co.jpSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.04% | 28.77M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock OncoTherapy Science, Inc. - Japan Exchange
- Company OncoTherapy Science, Inc.